Pharmacological profile of barnidipine: A single optical isomer dihydropyridine calcium antagonist

Blood Pressure

Volumn 7, Issue SUPPL. 1, 1998, Pages 5-8

  Van Zwieten, Pieter A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

barnidipine; calcium antagonist; chemistry; clinical pharmacology; enantiomers; lipophilicity

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; MEPIRODIPINE; NIFEDIPINE; NITRENDIPINE; 1,4 DIHYDROPYRIDINE; 1,4-DIHYDROPYRIDINE; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; CONFERENCE PAPER; DIURESIS; DRUG MECHANISM; DRUG METABOLISM; DRUG SELECTIVITY; DRUG STRUCTURE; ENANTIOMER; HEMODYNAMICS; HYPERTENSION; INOTROPISM; LIPOPHILICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STEREOCHEMISTRY; VASODILATATION; ANIMAL; CHEMISTRY; DOG; GUINEA PIG; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; DOGS; GUINEA PIGS; HYPERTENSION; NIFEDIPINE; RATS; RATS, INBRED SHR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031817654     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/080370598438537     Document Type: Conference Paper

References (13)

1. Nayler WG. Calcium antagonists. Eur Heart J 1980; 1: 225-37. (Pubitemid 11195346)
2. van Zwieten PA, Timmermans PBMWM, van Heiningen PNM. Receptor subtypes involved in the action of calcium antagonists. J Hypertens 1987; 5 (Suppl 4): S21-8. (Pubitemid 18035034)
3. Nayler WG. Calcium antagonists. London: Academic Press, Harcourt Brace Jovanovich Publ., 1988: 1-347.
4. Opie LH. Clinical use of calcium channel antagonistic drugs. 2nd ed. Boston: Kluwer Academic Publ., 1990: 70-130.
5. Gray Ellrodt A, Singh BN. Clinical applications of slow channel blocking compounds. Clin Pharmacol Ther 1983; 23: 1-43. (Pubitemid 14243133)
6. Satoh RH. Pharmacology and therapeutic effects of mepirodipine. Cardiovasc Drug Res 1991; 9: 340-56.
7. Tamazawa K, Arima H, Kojima T, et al. Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinylmethyl-2,6-dimethyl-4-(m-nitrophenyl) -1,4-dihydropyridine-3,5-dicarboxylate. J Med Chem 1986; 29: 2504-11. (Pubitemid 17211411)
8. Nakayama K, Kashiwabara S, Yamada S, et al. Assessment in pig coronary artery of long-lasting and potent calcium antagonistic actions of the novel dihydropyridine derivative mepirodipine hydrochloride. Arzneim Forsch 1989; 39: 50-5. (Pubitemid 19030785)
9. Kashiwabara T, Nakayama K, Yamanda S, Tanaka Y. Long-lasting and potent Ca-antagonistic actions of a novel dihydropyridine with two asymmetric centers (YM-09730-5) assessed in the porcine coronary artery. Jpn J Pharmacol 1987; Suppl 43: 731.
10. Kawashima K, Toda H, Oohata H, et al. Antihypertensive and diuretic effects of YM-09730-5, a new calcium antagonist, in stroke-prone spontaneously hypertensive rats. Gen Pharmacol 1991; 22: 263-6.
11. Inagaki O, Momose N, Nakagawa C, Honda K. Effects of YM-09730-5, a new calcium antagonist, on blood pressure and vasocontractor response in spontaneously hypertensive rats. Jpn J Pharmacol 1987; 43: 292.
12. Yatsu T, Takizawa K, Inagaki O, Shibasaki M, Honda K. Renal effects of YM-09730-5, a new dihydropyridine calcium antagonist in anaesthetized dogs. Jpn J Pharmacol 1988; Suppl 46: 227.
13. van Zwieten PA. Clinical pharmacology of calcium antagonists as antihypertensive and anti-anginal drugs. J Hypertens 1996; 14: S3-10.